Carmine Therapeutics
Developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€50—75m (Dealroom.co estimates Oct 2022.)
Cambridge Massachusetts (HQ)
Authorizing premium user...